Home /
Chemicals /
Caprolactam
Warning
GHS07
NOAEL Data
IARC Group 3
REACH Registered
Cosmetic Ingredient
Caprolactam
Also known as: 2H-Azepin-2-one, hexahydro-, 5-21-06-00444, 6-Aminocaproic acid lactam, 6-Aminohexanoic acid cyclic lactam, 2H-Azepin-7-one, hexahydro- (+15 more)
CAS 105-60-2
Caprolactam (CAS 105-60-2) is a chemical substance with GHS signal word Warning; key hazard signal: H332; H302; H335; H315; H319. Key regulatory status: REACH registered, 7 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from ECHA CLP, EPA ToxValDB, EPA CPDat, AICIS, IARC, ECHA REACH, ILO ICSC, OSHA.
View cosmetic safety profile for Caprolactam →
SOURCE
NOAEL studies
NOAEL studies
45
SOURCE
Chemical inventory jurisdictions
Regulatory lists
7
SOURCE
EU CLP Annex VI
GHS signal
Warning
Chemical Identity
CAS, identifiers, formula, and alternate names for the matched substance record.
SOURCE
DSSTox identifiers
26 fields
InChI Key
JBKVHLHDHHXQEQ-UHFFFAOYSA-N
Monoisotopic Mass
113.084064
Synonyms
2H-Azepin-2-one, hexahydro- 5-21-06-00444 6-Aminocaproic acid lactam 6-Aminohexanoic acid cyclic lactam 2H-Azepin-7-one, hexahydro- BRN 0106934 Caprolactam monomer Cyclohexanone iso-oxime EINECS 203-313-2 1,6-Hexalactam Hexamethylenimine, 2-oxo- Hexanoic acid, 6-amino-, lactam
IARC Carcinogen Classification
Carcinogenic hazard classification from IARC monograph evaluations.
SOURCE
IARC Monographs on the Identification of Carcinogenic Hazards to Humans
1 records
Group Meaning Evaluated Volume
Group 3 Not classifiable 1998 39, Sup 7, 71
GHS / CLP Classification
EU harmonized hazard classification, hazard statements, pictograms, and signal word.
SOURCE
EU CLP Annex VI (ECHA)
1 classifications
Hazard Class H-Statements Pictograms Signal
Acute Tox. 4 *; Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2 H332; H302; H335; H315; H319 GHS07 Warning
ICSC Chemical Safety
International Chemical Safety Card hazard and exposure summary.
SOURCE
WHO/JECFA
1 records
Field Value
GHS Signal Word WARNING
GHS Hazard Statements Harmful if swallowed Causes skin and eye irritation May cause drowsiness or dizziness
Short-term Effects The substance is irritating to the skin, eyes and respiratory tract. The substance may cause effects on the central nervous system.
Long-term Effects Repeated or prolonged contact with skin may cause dermatitis. The substance may have effects on the nervous system and liver.
Routes of Exposure The substance can be absorbed into the body by inhalation of its aerosol.
OSHA Exposure Limits
Occupational exposure limits from OSHA, NIOSH, and ACGIH rows.
SOURCE
OSHA / NIOSH / ACGIH occupational exposure limits
4 records
Agency Metric Value ppm mg/m3 Skin
NIOSH TWA 1 mg/m³ (dust), 0.22 ppm (1 mg/m³) (vapor) 0.22 1 N
ACGIH TWA 5 mg/m³ (inhalable fraction and vapor) [1997] - 5 N
CAL/OSHA TWA 1 mg/m³ [dust], 5 ppm (20 mg/m³) [vapor] 5 1 N
CAL/OSHA STEL 3 mg/m³ [dust], 10 ppm (40 mg/m³) [vapor] 10 3 N
Functional Uses
Industrial and product-use categories associated with this substance.
SOURCE
EPA CPDat
11 records
Flavouring and nutrient Filler Degradant/impurity Monomers No specific technical function
Regulatory Lists
Inventory, screening, and regulatory list matches from public chemical databases.
SOURCE
EPA CPDat
7 records
List Keyword Source
Europe European Commission Fl@vis
drinking_water; Europe; manufacturing; plastic_additive Belgaqua CPCat
Cons electronics mech appliances and machinery; Europe Danish Environmental Protection Agency Danish EPA
Arts and crafts/Office supplies - fabric treatment and dye; detected Danish Environmental Protection Agency Danish EPA
CEDI FDA United States Food and Drug Administration (FDA)
Arts and crafts/Office supplies - general arts and crafts supplies - arts and crafts paint; detected; Europe Danish Environmental Protection Agency Danish EPA
food_additive; Substances Added to Food (formerly EAFUS) (2/2019) FDA United States Food and Drug Administration (FDA)
NOAEL Studies
Toxicology endpoints rendered from public NOAEL study rows.
SOURCE
NOAEL studies
Showing 45 of 45 studies
Value Unit Endpoint Route Species Source
=3 mg/m3 BMCL (05) inhalation Rat ToxValDB Cal OEHHA REL derivations
- uL/min/10^6 cells Clint - Human NTP ICE adme parameters
- uL/min/10^6 cells Clint - Rat NTP ICE adme parameters
=5 mg/m3 DNEL local inhalation Human ToxValDB GESTIS DNEL
6879X594Z8 UNII FDA UNII substance identifier - - openFDA substances
6879X594Z8 UNII FDA UNII substance identifier - - openFDA substances
6879X594Z8 UNII FDA UNII substance identifier - - openFDA substances
6879X594Z8 UNII FDA UNII substance identifier - - openFDA substances
0.761 fraction Fu - Human NTP ICE adme parameters
3 IARC group IARC carcinogenicity classification - - IARC Monographs
3 IARC group IARC carcinogenicity classification - - IARC Monographs
3 IARC group IARC carcinogenicity classification - - IARC Monographs
3 unitless IARC group - - NTP ICE cancer
0.3 mg/L LC50 Inhalation - NTP ICE acute inhalation
=31 mg/kg bw/day LEL oral Rat ToxValDB ToxRefDB
=31 mg/kg bw/day LEL oral rat (fischer; Fischer 344) EPA ToxRefDB v3
=125 mg/kg bw/day LEL oral Rat ToxValDB ToxRefDB
=125 mg/kg bw/day LEL oral rat (fischer; Fischer 344) EPA ToxRefDB v3
=188 mg/kg bw/day LEL oral Rat ToxValDB ToxRefDB
=188 mg/kg bw/day LEL oral rat (fischer; Fischer 344) EPA ToxRefDB v3
=750 mg/kg bw/day LEL oral Mouse ToxValDB ToxRefDB
=750 mg/kg bw/day LEL oral mouse (b6c3f1; B6C3F1) EPA ToxRefDB v3
=1125 mg/kg bw/day LEL oral Mouse ToxValDB ToxRefDB
=1125 mg/kg bw/day LEL oral mouse (b6c3f1; B6C3F1) EPA ToxRefDB v3
=47 mg/m3 LOAEL inhalation Human ToxValDB EU SCOEL
=250 mg/kg bw/day LOAEL oral Rat ToxValDB IRIS
=425 ppm LOEL oral Rat ToxValDB ECOTOX
- unitless Model Score - - NTP ICE endocrine
>- mg/kg bw/day NEL oral rat (fischer; Fischer 344) EPA ToxRefDB v3
=63 mg/kg bw/day NEL oral Rat ToxValDB ToxRefDB
=63 mg/kg bw/day NEL oral rat (fischer; Fischer 344) EPA ToxRefDB v3
=0.5 mg/m3 NOAEL inhalation Human ToxValDB Cal OEHHA REL derivations
=33 mg/m3 NOAEL inhalation Human ToxValDB EU SCOEL
=50 mg/kg bw/day NOAEL oral Rat ToxValDB IRIS
=50 mg/kg/day NOAEL oral - Regulatory source
=500 mg/kg bw/day NOEL oral Mouse ToxValDB ECOTOX
=700 mg/kg bw/day NOEL oral Rat ToxValDB ECOTOX
=750 mg/kg bw/day NOEL oral Rat EFSA
=750 mg/kg bw/day NOEL oral: feed Rat EFSA
=750 mg/kg bw/day NOEL oral: feed Rat EFSA
=0.0022 mg/m3 RfC inhalation Human ToxValDB RSL
=0.5 mg/kg bw/day RfD oral Human ToxValDB IRIS
=0.5 mg/kg/day RfD oral - Regulatory source
7500 ppm Top dose Dosed feed Rat NTP ICE cancer
15000 ppm Top dose Dosed feed Mouse NTP ICE cancer
Showing 45 of 45 studies
REACH Registration
Registration status from the ECHA REACH registered substances database.
SOURCE
ECHA
1 records
Australian Status (AICIS)
Australian industrial chemicals inventory status and applicable conditions.
SOURCE
AICIS inventory
1 records
Cosmetic Safety Profile
Same-CAS cosmetic ingredient record for cross-vertical context.
SOURCE
CosIng / Ingredients DB
Category
Cosmetic Ingredient
View full cosmetic safety profile →
Cannabis Data
Same-CAS cannabis compliance and lab records where available.
SOURCE
Cannabis regulatory / lab data
efsa substances
1 cannabis record found in efsa substances.
View full cannabis profile →
Frequently Asked Questions
What is the GHS hazard classification for Caprolactam?
Caprolactam (CAS 105-60-2) is classified under EU CLP Annex VI as Acute Tox. 4 *; Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2 with signal word Warning. Hazard statements: H332; H302; H335; H315; H319. Source: EU CLP Annex VI (ECHA).
What is the NOAEL for Caprolactam?
Caprolactam has 45 NOAEL studies in the database. The lowest reported value is 0 uL/min/10^6 cells in Human. Source: NTP ICE adme parameters.
What regulatory lists include Caprolactam?
Caprolactam appears on 7 regulatory/inventory lists including Europe, drinking_water; Europe; manufacturing; plastic_additive, Cons electronics mech appliances and machinery; Europe, and 4 more. Source: EPA CPDat.
Is Caprolactam a carcinogen according to IARC?
Caprolactam is classified by IARC as Group 3 — not classifiable as to its carcinogenicity to humans (evaluated 1998). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
What are the occupational exposure limits for Caprolactam?
Occupational exposure limits for Caprolactam are set by NIOSH, ACGIH, CAL/OSHA. 4 limit values from official agencies are documented in the database. Source: OSHA, NIOSH, ACGIH.
Is Caprolactam used in cosmetics?
Yes, Caprolactam is also indexed as a cosmetic ingredient under the name Caprolactam. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Where does the safety data for Caprolactam come from?
Safety data is sourced from ECHA CLP Annex VI, EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, IARC Monographs, ECHA REACH, ILO/WHO ICSC, OSHA/NIOSH/ACGIH, CosIng / Ingredients DB, ChEMBL / DailyMed, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Is Caprolactam used outside industrial chemicals?
Caprolactam also appears in cosmetics, pharmaceutical, cannabis databases.